Canadians last year spent $16.8 billion on patented medicines including drugs sold at higher prices here than in select European countries, a federal agency yesterday reported. The Patented Medicine Prices Review Board described the growth in sales of high-priced drugs, those costing $10,000 or more, as “remarkable”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
